Literature DB >> 15322000

Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease.

Hideko Kajiwara1, Mitsumasa Saito, Shouichi Ohga, Takeshi Uenotsuchi, Shin-ichi Yoshida.   

Abstract

We compared the immune defense of mice with chronic granulomatous disease (CGD mice) with that of wild-type C57BL/6 mice for their response to Sporothrix schenckii. A subcutaneous injection of 5 x 10(4) CFU S. schenckii strain IFM41598 into CGD mice resulted in systemic infection and death within 84 days. In contrast, injected C57BL/6 mice did not develop systemic infection and were able to survive through 100 days of observation. Differences in host resistance were analyzed in vitro. Neutrophils and macrophages obtained from CGD mice were found to allow greater growth of this organism than did those obtained from C57BL/6 mice. Moreover, macrophages obtained from immunized CGD mice were able to simply inhibit the growth of this fungus whereas macrophages obtained from immunized C57BL/6 mice killed the fungus within 48 h after phagocytosis. These results suggest that (i) the lack of NADPH oxidase function is a risk factor for lethal S. schenckii infection and (ii) superoxide anion and its reactive oxidative metabolites produced by neutrophils and macrophages are involved in fungistatic and fungicidal activities.

Entities:  

Mesh:

Year:  2004        PMID: 15322000      PMCID: PMC517470          DOI: 10.1128/IAI.72.9.5073-5079.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice.

Authors:  T Tachibana; T Matsuyama; M Mitsuyama
Journal:  Med Mycol       Date:  1999-12       Impact factor: 4.076

2.  Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions.

Authors:  K J Kwon-Chung
Journal:  J Infect Dis       Date:  1979-04       Impact factor: 5.226

3.  Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, and muramyl dipeptide of candidacidal activity of mouse macrophages.

Authors:  R T Nozawa; R Sekiguchi; T Yokota
Journal:  Cell Immunol       Date:  1980-07-15       Impact factor: 4.868

4.  Phagocytosis and intracellular fate of Sporothrix schenckii.

Authors:  K M Cunningham; G S Bulmer; E R Rhoades
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

5.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

6.  Virulence of Sporothrix schenckii conidia and yeast cells, and their susceptibility to nitric oxide.

Authors:  K S Fernandes; A L Coelho; L M Lopes Bezerra; C Barja-Fidalgo
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

7.  Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components.

Authors:  Karla S S Fernandes; Herbert L Mathews; Leila M Lopes Bezerra
Journal:  J Med Microbiol       Date:  1999-02       Impact factor: 2.472

8.  Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

Authors:  M S Cohen; R E Isturiz; H L Malech; R K Root; C M Wilfert; L Gutman; R H Buckley
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

9.  Susceptibility of congenitally athymic (nude) mice to sporotrichosis.

Authors:  C L Dickerson; R L Taylor; D J Drutz
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans.

Authors:  Yasuaki Aratani; Fumiaki Kura; Haruo Watanabe; Hisayoshi Akagawa; Yukie Takano; Kazuo Suzuki; Mary C Dinauer; Nobuyo Maeda; Hideki Koyama
Journal:  J Infect Dis       Date:  2002-05-16       Impact factor: 5.226

View more
  11 in total

1.  Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection.

Authors:  Rodrigo Almeida-Paes; Monique A Pimenta; Claudia Vera Pizzini; Paulo Cezar F Monteiro; José Mauro Peralta; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

Review 2.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Keratinocyte Response to Infection with Sporothrix schenckii.

Authors:  Araceli Paredes-Rojas; Alejandro Palma-Ramos; Laura Estela Castrillón-Rivera; Felipe Mendoza-Pérez; María Del Carmen Navarro-González; Roberto Arenas-Guzmán; Jorge Ismael Castañeda-Sánchez; Julieta Luna-Herrera
Journal:  J Fungi (Basel)       Date:  2022-04-23

4.  Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease.

Authors:  Jessica R Trotter; Panida Sriaroon; David Berman; Aleksandra Petrovic; Jennifer W Leiding
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

5.  The role of reactive oxygen intermediates in experimental coccidioidomycois in mice.

Authors:  David A Margolis; Suganya Viriyakosol; Joshua Fierer; Theo N Kirkland
Journal:  BMC Microbiol       Date:  2011-04-11       Impact factor: 3.605

6.  Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model.

Authors:  Feng Chen; Rihua Jiang; Yicun Wang; Mingji Zhu; Xu Zhang; Shuai Dong; Hongxi Shi; Li Wang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

7.  An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis.

Authors:  José Roberto Fogaça de Almeida; Grasielle Pereira Jannuzzi; Gilberto Hideo Kaihami; Leandro Carvalho Dantas Breda; Karen Spadari Ferreira; Sandro Rogério de Almeida
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

Review 8.  Immunity and Treatment of Sporotrichosis.

Authors:  Laura Cristina García Carnero; Nancy Edith Lozoya Pérez; Sandra Elizabeth González Hernández; José Ascención Martínez Álvarez
Journal:  J Fungi (Basel)       Date:  2018-08-20

9.  Exogenous Local Hyperthermia at 41℃ Is Effective to Eliminate Mouse Model of Sporotrichosis, Independent of Neutrophil Extracellular Traps Formation.

Authors:  Ya-Lan Wang; Rui-Qun Qi; Jing Lan; Zheng-Xiu Li; Xing-Hua Gao
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

10.  Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis.

Authors:  Elaine Waite de Souza; Cintia de Moraes Borba; Sandro Antonio Pereira; Isabella Dib Ferreira Gremião; Ingeborg Maria Langohr; Manoel Marques Evangelista Oliveira; Raquel de Vasconcellos Carvalhaes de Oliveira; Camila Rocha da Cunha; Rosely Maria Zancopé-Oliveira; Luisa Helena Monteiro de Miranda; Rodrigo Caldas Menezes
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.